A detailed history of Pathstone Holdings, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Pathstone Holdings, LLC holds 290,229 shares of NVO stock, worth $25.4 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
290,229
Previous 289,495 0.25%
Holding current value
$25.4 Million
Previous $41.3 Million 16.37%
% of portfolio
0.16%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$119.07 - $145.42 $87,397 - $106,738
734 Added 0.25%
290,229 $34.6 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $1.5 Million - $1.79 Million
12,207 Added 4.4%
289,495 $41.3 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $12.5 Million - $16.6 Million
122,229 Added 78.83%
277,288 $35.6 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $13.6 Million - $16.4 Million
155,059 New
155,059 $16 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.